PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

SUVRETTA CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001569064)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024

Shares 30,500 Value ($000) $1,057 Avg Close $29.29 Range $24.22 - $35.96

Q1 2024

Shares 30,500 Value ($000) $882 Avg Close $27.21 Range $21.43 - $33.34

Q3 2023

Shares 108,308 Value ($000) $1,807 Avg Close $19.40 Range $16.33 - $26.81

Q2 2023

Shares 81,143 Value ($000) $2,241 Avg Close $25.03 Range $17.64 - $30.10

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2024	30,500	$1,057	$29.29	$24.22 - $35.96
Q1 2024	30,500	$882	$27.21	$21.43 - $33.34
Q3 2023	108,308	$1,807	$19.40	$16.33 - $26.81
Q2 2023	81,143	$2,241	$25.03	$17.64 - $30.10